About the KONFIDENT StudyAbout the KOMPLETE StudyAbout the Effectus Patient Identification ProgramSign Up Here

Do you see adolescent and adult patients with hereditary angioedema (HAE) type I or type II?

Learn how you can get involved to support a nearby study that is enrolling qualified patients.

About the KONFIDENT Research Study

KalVista Pharmaceuticals is currently conducting the KONFIDENT Study. The purpose of the KONFIDENT Study is to understand the effects of an investigational oral medication, KVD900, in patients 12 years of age and older with HAE type I or type II. The study is evaluating 2 different doses to see which one may be best as a safe on-demand treatment for HAE attacks.

KVD900 is an investigational oral medication designed for on-demand treatment for HAE attacks. It works by inhibiting the activation of plasma kallikrein, which reduces swelling and may help in the treatment of HAE.

For more information about the study and investigational drug, please visit: https://konfidentstudy.com

How You Can Get Involved

As a physician who sees patients with HAE, you are invited to participate in the Effectus Patient Identification and Consultation Program to help identify candidates for the KONFIDENT Study. You will be asked to consult with patients in a neutral manner about the study and assess their interest in participating at a nearby study site. Patients may be able to take part if they meet high-level criteria (key study criteria will be provided to you upon onboarding). At the study site, patients will undergo formal study screening to determine eligibility.

Compensation at fair market value will be available for physicians who participate and meet program requirements.

The Effectus Patient Identification and Consultation Program

    Thank you for expressing preliminary interest in partnering with Effectus to support an HAE study being conducted near you. Please provide your contact information below and a member of the Effectus team will reach out with more information. Should you have any questions prior, please call us at 973-753-2430.

    *Please provide the following information:

    Name:

    Specialty:

    Email Address:

    Phone Number:

    By opting-in and completing this Consent Form, you consent to your personal information being processed by or on behalf of Effectus for the purposes set forth herein.

    Your Personal Information:

    • We collect and process your personal information to (1) notify you about program opportunities, and (2) pay your compensation should you participate in a program.

    • If you are located outside the US, your personal information may be transferred to the US and disclosed to our US service providers.

    • We will retain your personal information only for the time necessary to accomplish the purposes stated herein and to comply with applicable laws.

    • We will not share or sell your personal information outside of Effectus.

    Healthcare providers who reside in the state of Vermont are ineligible for participation. 

    89 Headquarters Plaza North, Suite #1450, Morristown, NJ 07960

    Do you see adult patients with hereditary angioedema (HAE) type I or type II?

    Learn how you can get involved to support a nearby study that is enrolling qualified patients.

    About the KOMPLETE Research Study

    KalVista Pharmaceuticals is currently conducting the KOMPLETE Study. The purpose of the KOMPLETE Study is to understand the effects of an investigational oral medication, KVD824, in adults 18 years of age and older with HAE type I or type II. The study is evaluating 3 different doses to see which one may be best as a safe prophylaxis treatment for HAE attacks.

    KVD824 is an investigational oral medication designed to prevent HAE attacks. It works by inhibiting the activation of plasma kallikrein, which reduces swelling and may help in the treatment of HAE.

    For more information about the study and investigational drug, please visit: https://kompletestudy.com

    How You Can Get Involved

    As a physician who sees patients with HAE, you are invited to participate in the Effectus Patient Identification and Consultation Program to help identify candidates for the KOMPLETE Study. You will be asked to consult with patients in a neutral manner about the study and assess their interest in participating at a nearby study site. Patients may be able to take part if they meet high-level criteria (key study criteria will be provided to you upon onboarding). At the study site, patients will undergo formal study screening to determine eligibility.

    Compensation at fair market value will be available for physicians who participate and meet program requirements.

    The Effectus Patient Identification and Consultation Program

      Thank you for expressing preliminary interest in partnering with Effectus to support an HAE study being conducted near you. Please provide your contact information below and a member of the Effectus team will reach out with more information. Should you have any questions prior, please call us at 973-753-2430.

      *Please provide the following information:

      Name:

      Specialty:

      Email Address:

      Phone Number:

      By opting-in and completing this Consent Form, you consent to your personal information being processed by or on behalf of Effectus for the purposes set forth herein.

      Your Personal Information:

      • We collect and process your personal information to (1) notify you about program opportunities, and (2) pay your compensation should you participate in a program.

      • If you are located outside the US, your personal information may be transferred to the US and disclosed to our US service providers.

      • We will retain your personal information only for the time necessary to accomplish the purposes stated herein and to comply with applicable laws.

      • We will not share or sell your personal information outside of Effectus.

      Healthcare providers who reside in the state of Vermont are ineligible for participation. 

      89 Headquarters Plaza North, Suite #1450, Morristown, NJ 07960

      Effectus Patient Identification and Consultation Program Overview

      Support Provided

      Effectus will be your trusted partner throughout your participation, helping to facilitate your patients to the study site and thus relieving the burden on your practice. If you wish to participate, you will be asked to review and sign a Services Agreement with Effectus, which outlines your program responsibilities and compensation. Participation is completely voluntary, and you can opt out at any time. Background on the studies, program materials, and program logistics will be reviewed in detail during a 1-hour virtual training session.

      Why Participate?

      The program provides an opportunity to contribute to the research and advancement of a potential new prophylaxis and on-demand treatment for HAE attacks. The study also allows physicians the opportunity to offer alternative potential treatment options to their patients.

      Sign a services
      agreement.

      Receive a package of
      program materials and
      complete a simple, one-hour
      virtual training session.

      Utilize key screening
      criteria to identify
      potentially eligible
      patients.

      If the patient meets the criteria,
      conduct a neutral consultation
      about the availability of the
      nearby study and gauge the
      patient’s interest.

      If the patient is interested in
      participation, our team of dedicated
      Patient Facilitators help ensure a
      smooth patient transfer from your
      office to the study.

      The patient is scheduled
      and presents at the study
      site for the screening
      appointment.

      The patient’s enrollment
      status is determined and is
      relayed back to the treating
      HCP by Effectus.

      For more information on our program, please visit https://www.effectusctr.com/physician-network/.

      The Effectus Patient Identification and Consultation Program

        Thank you for expressing preliminary interest in partnering with Effectus to support an HAE study being conducted near you. Please provide your contact information below and a member of the Effectus team will reach out with more information. Should you have any questions prior, please call us at 973-753-2430.

        *Please provide the following information:

        Name:

        Specialty:

        Email Address:

        Phone Number:

        By opting-in and completing this Consent Form, you consent to your personal information being processed by or on behalf of Effectus for the purposes set forth herein.

        Your Personal Information:

        • We collect and process your personal information to (1) notify you about program opportunities, and (2) pay your compensation should you participate in a program.

        • If you are located outside the US, your personal information may be transferred to the US and disclosed to our US service providers.

        • We will retain your personal information only for the time necessary to accomplish the purposes stated herein and to comply with applicable laws.

        • We will not share or sell your personal information outside of Effectus.

        Healthcare providers who reside in the state of Vermont are ineligible for participation. 

        89 Headquarters Plaza North, Suite #1450, Morristown, NJ 07960

        Contact Us

        Montana Markell, Project Coordinator

        Phone: 973-753-2430

        Email: mmarkell@effectusctr.com

        Scroll to top

        This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

        I AgreeLearn More×

        Cookie and Privacy Settings



        How we use cookies

        We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

        Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

        Essential Website Cookies

        These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

        Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.

        Google Analytics Cookies

        These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

        If you do not want that we track your visist to our site you can disable tracking in your browser here:

        Privacy Policy

        You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

        Privacy Policy
        5
        Accept settingsHide notification only